|
⚲
|
| Keyboard |
| Aquilo Capital Management LLC
✚
|
|
|---|---|
| CRD # | 153022 |
| SEC # | 801-111633 |
| CIK # | 0001591986 |
| AUM | |
| Employees | 5 (100% Investors, 0% Brokers) |
| Phone | 415-635-0140 |
| Address | One Letterman Drive San Francisco, CA 94129 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
| Total AUM ($M) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| HF | Aquilo Capital Special Opportunity LP | [2021-03-31] | 16.2 M | 19.4 M |
| Filed 2023-08-23 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| Other | Aquilo Capital Lo LP | [2017-08-07] | 212.5 M | 87.6 M |
| Filed 2024-11-19 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Finder's Fee $1,344,084 · Net Assets Decline to Disclose | ||||
| HF | Aquilo Capital LP | [2015-04-06] | 257.0 M | 170.0 M |
| Filed 2024-11-19 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Finder's Fee $2,091,593 · Net Assets Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 4 | 257.6 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 4 | 257.6 |
| By Discretionary | ||
| Discretionary | 4 | 257.6 |
| Non-Discretionary | 0 | 0.0 |
| Total | 4 | 257.6 |
| By Non-United States Persons | ||
| Non-United States Persons | 50.2 | |
| United States Persons | 207.4 | |
| Total | 4 | 257.6 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Marc Schneidman | Executive Officer | 4 | 2 | |
| Aquilo Capital Management LLC | Executive Officer | 3 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001591986] | |
| 3 | [0001591986] | |
| 4 | [0001591986] | |
| SC 13G | [0001591986] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Fund Types | Hedge Fund |
| LEI | 254900J03UBQSFDMNU40 |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Aquilo Capital LP | |
| Aquilo Capital Management LLC | |
| Spero Therapeutics Inc | |
| Palvella Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Spero Therapeutics Inc SPRO
Common Stock, $0.001 par value
|
2022-09-22 | Sell | 1,335,512 | $2.25 | 3,004,902 |
|
Spero Therapeutics Inc SPRO
Common Stock, $0.001 par value
|
2022-09-22 | Sell | 566,284 | $2.25 | 1,274,139 |
|
Spero Therapeutics Inc SPRO
Common Stock, $0.001 par value
|
2022-04-26 | Buy | 39,727 | $5.24 | 208,169 |
|
Spero Therapeutics Inc SPRO
Common Stock, $0.001 par value
|
2022-03-30 | Buy | 16,885 | $8.79 | 148,419 |
|
Spero Therapeutics Inc SPRO
Common Stock, $0.001 par value
|
2022-03-30 | Buy | 33,115 | $8.79 | 291,081 |
|
Spero Therapeutics Inc SPRO
Common Stock, $0.001 par value
|
2022-03-14 | Buy | 8,006 | $7.63 | 61,086 |
|
Spero Therapeutics Inc SPRO
Common Stock, $0.001 par value
|
2022-03-14 | Buy | 15,702 | $7.63 | 119,806 |
|
Spero Therapeutics Inc SPRO
Common Stock, $0.001 par value
|
2022-02-28 | Buy | 29,729 | $9.53 | 283,317 |
|
Spero Therapeutics Inc SPRO
Common Stock, $0.001 par value
|
2022-02-28 | Buy | 15,104 | $9.53 | 143,941 |
|
Spero Therapeutics Inc SPRO
Common Stock, $0.001 par value
|
2022-02-18 | Buy | 14,828 | $9.24 | 137,011 |
|
Spero Therapeutics Inc SPRO
Common Stock, $0.001 par value
|
2022-01-31 | Buy | 125,000 | $11.59 | 1,448,750 |
|
Spero Therapeutics Inc SPRO
Common Stock, $0.001 par value
|
2022-01-24 | Buy | 1,599 | $10.89 | 17,413 |
|
Spero Therapeutics Inc SPRO
Common Stock, $0.001 par value
|
2022-01-18 | Buy | 48,488 | $12.41 | 601,736 |
|
Spero Therapeutics Inc SPRO
Common Stock, $0.001 par value
|
2022-01-10 | Buy | 8,867 | $12.93 | 114,650 |
|
Spero Therapeutics Inc SPRO
Common Stock, $0.001 par value
|
2021-12-31 | Buy | 125,000 | $15.75 | 1,968,750 |
|
Spero Therapeutics Inc SPRO
Common Stock, $0.001 par value
|
2021-12-30 | Buy | 50,000 | $15.77 | 788,500 |
|
Spero Therapeutics Inc SPRO
Common Stock, $0.001 par value
|
2021-12-29 | Buy | 75,493 | $14.64 | 1,105,218 |
|
Spero Therapeutics Inc SPRO
Common Stock, $0.001 par value
|
2021-10-29 | Buy | 150,000 | $17.53 | 2,629,500 |
|
Spero Therapeutics Inc SPRO
Common Stock, $0.001 par value
|
2021-09-30 | Buy | 134,543 | $18.65 | 2,509,227 |
|
Spero Therapeutics Inc SPRO
Common Stock, $0.001 par value
|
2021-09-14 | Buy | 2,156 | $18.49 | 39,864 |
| showing 20 of 41 most recent transactions | |||||